Literature DB >> 10834708

Is prostacyclin responsible for producing the hyperdynamic response during early sepsis?

P Wang1, M Zhou, W G Cioffi, K I Bland, Z F Ba, I H Chaudry.   

Abstract

OBJECTIVE: Although polymicrobial sepsis is characterized by an early hyperdynamic phase (2-10 hrs after cecal ligation and puncture [CLP]), followed by a late hypodynamic phase (20 hrs after CLP), it remains unknown whether prostacyclin or prostaglandin I2 (PGI2) plays a significant role in modulating the hyperdynamic state during early sepsis. The aim of this study was to determine whether inhibition of PGI2 synthesis prevents the occurrence of the hyperdynamic response during early sepsis.
DESIGN: Prospective, controlled animal study.
SETTING: A university research laboratory.
SUBJECTS: Adult male Sprague-Dawley rats were subjected to sepsis by CLP. INTERVENTIONS AND MEASUREMENTS: Blood samples were collected at 2, 5, 10, or 20 hrs after CLP, and plasma concentrations of PGI2, in the form of its stable product 6-keto-PGF1alpha, were measured by radioimmunoassay. In additional studies, a PGI2 synthase inhibitor, tranylcypromine, was administered subcutaneously at the time of CLP and again at 3 hrs after CLP. At 5 hrs after the onset of sepsis, the maximal rates of the left ventricular pressure rise (+dP/dtmax) and fall (-dP/dtmax) were determined by an in vivo heart performance analyzer. Microvascular blood flow in the liver, small intestine, and spleen was assessed by laser Doppler flowmetry. MAIN
RESULTS: Plasma concentrations of 6-keto-PGF1alpha increased significantly at 2-20 hrs after CLP. At 5 hrs after the onset of sepsis, +/-dP/dt(max) and microvascular blood flow in the tested tissues increased significantly. Inhibition of PGI2 synthase activity did not prevent the occurrence of hypercardiovascular responses under such conditions. Moreover, the administration of tranylcypromine significantly reduced circulating concentrations of 6-keto-PGF1alpha at 5 hrs after CLP.
CONCLUSIONS: Because inhibition of PGI2 production did not prevent the occurrence of the hyperdynamic and hypercardiovascular response during the early stage of sepsis, mediators other than PGI2 appear to play a major role in producing the hyperdynamic response under such conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10834708     DOI: 10.1097/00003246-200005000-00046

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  7 in total

1.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

Review 2.  Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.

Authors:  B Levy; S Collin; N Sennoun; N Ducrocq; A Kimmoun; P Asfar; P Perez; F Meziani
Journal:  Intensive Care Med       Date:  2010-09-23       Impact factor: 17.440

Review 3.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

4.  Inhibition of aldose reductase prevents endotoxin-induced inflammation by regulating the arachidonic acid pathway in murine macrophages.

Authors:  Mohammad Shoeb; Umesh C S Yadav; Satish K Srivastava; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-08-05       Impact factor: 7.376

5.  The effects of anisodamine and dobutamine on gut mucosal blood flow during gut ischemia/ reperfusion.

Authors:  Sen Hu; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Reduction of lipopolysaccharide-induced cyclooxygenase-2 expression in diabetic arteries.

Authors:  Yuji Takahashi; Michael Poteser; Munetaka Negoro; Ichiro Wakabayashi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-01-20       Impact factor: 3.000

7.  Effects of lornoxicam on the physiology of severe sepsis.

Authors:  Dilek Memiş; Beyhan Karamanlioğlu; Alparslan Turan; Onur Koyuncu; Zafer Pamukçu
Journal:  Crit Care       Date:  2004-10-27       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.